Specifically, Notch3 enhances the progression of CRC by increasing the infiltration of macrophages and myeloid-derived suppressor cells (MDSCs) to promote the immunosuppressive TME [187]. This evidence concerns the gene NOTCH3 and colorectal carcinoma.